|
1) Licatalosi DD, Darnell RB. Splicing regulation in neurologic disease. Neuron. 2006; 52: 93-101
|
|
|
|
2) OʼRourke JR, Swanson MS. Mechanisms of RNA-mediated disease. J Biol Chem. 2009; 284: 7419-23
|
|
|
|
|
|
3) Gao K, Masuda A, Matsuura T, et al. Human branch point consensus sequence is yUnAy. Nucleic Acids Res. 2008; 36: 2257-67
|
|
|
|
|
|
4) Fu Y, Masuda A, Ito M, et al. AG-dependent 3ʼ-splice sites are predisposed to aberrant splicing due to a mutation at the first nucleotide of an exon. Nucleic Acids Res. 2011; 39: 4396-404
|
|
|
|
|
|
5) Gorlov IP, Gorlova OY, Frazier ML, et al. Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers. Am J Hum Genet. 2003; 73: 1157-61
|
|
|
|
|
|
6) Masuda A, Shen XM, Ito M, et al. hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome. Hum Mol Genet. 2008; 17: 4022-35
|
|
|
|
|
|
7) Bian Y, Masuda A, Matsuura T, et al. Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome. Hum Mol Genet. 2009; 18: 1229-37
|
|
|
|
|
|
8) Doktor TK, Schroeder LD, Vested A, et al. SMN2 exon 7 splicing is inhibited by binding of hnRNP A1 to a common ESS motif that spans the 3ʼ splice site. Hum Mutat. 2011; 32: 220-30
|
|
|
|
|
|
9) Hua Y, Sahashi K, Rigo F, et al. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature. 2011; 478: 123-6
|
|
|
|
|
|
10) Brichta L, Holker I, Haug K, et al. In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate. Ann Neurol. 2006; 59: 970-5
|
|
|
|
|
|
11) Sahashi K, Masuda A, Matsuura T, et al. In vitro and in silico analysis reveals an efficient algorithm to predict the splicing consequences of mutations at the 5ʼ splice sites. Nucleic Acids Res. 2007; 35: 5995-6003
|
|
|
|
|
|
12) Kishore S, Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science. 2006; 311: 230-2
|
|
|
|
|
|
13) Ohe K, Mayeda A. HMGA1a trapping of U1 snRNP at an authentic 5ʼ splice site induces aberrant exon skipping in sporadic Alzheimerʼs disease. Mol Cell Biol. 2010; 30: 2220-8
|
|
|
|
|
|
14) McKeon A, Pittock SJ. Paraneoplastic encephalo-myelopathies: pathology and mechanisms. Acta Neuropathol (Berl). 2011 Sep 22. [Epub ahead of print]
|
|
|
|
|
|
15) Licatalosi DD, Mele A, Fak JJ, et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature. 2008; 456: 464-9
|
|
|
|
|
|
16) Zhang C, Frias MA, Mele A, et al. Integrative modeling defines the Nova splicing-regulatory network and its combinatorial controls. Science. 2010; 329: 439-43
|
|
|
|
|
|
17) Zhang C, Darnell RB. Mapping in vivo protein-RNA interactions at single-nucleotide resolution from HITS-CLIP data. Nat Biotechnol. 2011; 29: 607-14
|
|
|
|
|
|
18) Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314: 130-3
|
|
|
|
|
|
19) Kwiatkowski TJ, Jr, Bosco DA, Leclerc AL, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009; 323: 1205-8
|
|
|
|
|
|
20) Vance C, Rogelj B, Hortobagyi T, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009; 323: 1208-11
|
|
|
|
|
|
21) Mackenzie IR, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010; 9: 995-1007
|
|
|
|
|
|
22) Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet. 2010; 19: R46-64
|
|
|
|
|
|
23) Ranum LP, Cooper TA. RNA-mediated neuromuscular disorders. Annu Rev Neurosci. 2006; 29: 259-77
|
|
|
|
|
|
24) Fugier C, Klein AF, Hammer C, et al. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat Med. 2011; 17: 720-5
|
|
|
|
|
|
25) Lim J, Crespo-Barreto J, Jafar-Nejad P, et al. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature. 2008; 452: 713-8
|
|
|
|
|
|
26) Moseley ML, Zu T, Ikeda Y, et al. Bidirectional expression of CUG and CAG expansion tran-scripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet. 2006; 38: 758-69
|
|
|
|
|
|
27) Rudnicki DD, Holmes SE, Lin MW, et al. Huntingtonʼs disease--like 2 is associated with CUG repeat-containing RNA foci. Ann Neurol. 2007; 61: 272-82
|
|
|
|
|